ArticlePloS one2015

Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

Susana Gordo-Remartínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.